Center for Vital Longevity, School of Behavioral and Brain Sciences, The University of Texas at Dallas.
Psychol Aging. 2018 Feb;33(1):109-118. doi: 10.1037/pag0000217.
Decline in associative memory abilities is a common cognitive complaint among older adults and is detectable in both normal aging and in prodromal Alzheimer's disease (AD). Subjective memory (SM) complaints may serve as an earlier marker of these mnemonic changes; however, previous research examining the predictive utility of SM to observed memory performance yielded inconsistent results. This inconsistency is likely due to other sources of variance that occur with memory decline such as mood/depression issues, presence of apolipoprotein E (APOE ε4) genotype, or beta-amyloid deposition. Here we examine the relationship between SM and associative memory ability in the context of factors that increase susceptibility to AD in 195 healthy adults (79 men) aged 20-94 years. Participants completed an SM questionnaire, a mood/depression scale, two associative memory tests (a word-pair and a name-face test), and were genotyped for APOE ε4. PET-amyloid imaging data were collected for a subset of those over 50 years of age (N = 74). We found that SM predicted performance on both associative memory tests even after covarying for age, sex, mood, and APOE ε4 status. Interestingly, for the name-face associative task, increased SM concerns predicted memory performance selectively in participants over the age of 60, with the APOEε4 risk group showing the strongest effect. Finally, men with higher beta-amyloid deposition reported more memory complaints. Our findings suggest that SM reliably tracks memory performance, even in cognitively healthy adults, and may reflect an increased risk for AD. (PsycINFO Database Record
关联记忆能力下降是老年人常见的认知主诉,在正常衰老和前驱性阿尔茨海默病(AD)中均可检测到。主观记忆(SM)主诉可能是这些记忆变化的早期标志物;然而,先前研究检查 SM 对观察到的记忆表现的预测效用得出了不一致的结果。这种不一致性可能是由于记忆下降时出现的其他来源的变化所致,例如情绪/抑郁问题、载脂蛋白 E(APOE ε4)基因型的存在或β-淀粉样蛋白沉积。在这里,我们在增加 AD 易感性的因素背景下检查了 SM 与联想记忆能力之间的关系,这些因素包括 195 名健康成年人(79 名男性)的年龄在 20-94 岁之间。参与者完成了一份 SM 问卷、一份情绪/抑郁量表、两项联想记忆测试(单词对和姓名面孔测试),并进行了 APOE ε4 基因分型。对于其中超过 50 岁的一部分参与者(N=74),我们还收集了 PET-淀粉样蛋白成像数据。我们发现,即使在考虑年龄、性别、情绪和 APOE ε4 状态后,SM 也可以预测两项联想记忆测试的表现。有趣的是,对于姓名面孔联想任务,SM 关注度的增加仅能预测年龄在 60 岁以上的参与者的记忆表现,而 APOEε4 风险组的影响最大。最后,β-淀粉样蛋白沉积较高的男性报告的记忆主诉更多。我们的研究结果表明,SM 可以可靠地跟踪记忆表现,即使在认知健康的成年人中也是如此,并且可能反映出 AD 的风险增加。